Yan Jiao

3.0k total citations · 1 hit paper
95 papers, 2.1k citations indexed

About

Yan Jiao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yan Jiao has authored 95 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 38 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yan Jiao's work include RNA modifications and cancer (19 papers), Cancer-related molecular mechanisms research (17 papers) and MicroRNA in disease regulation (10 papers). Yan Jiao is often cited by papers focused on RNA modifications and cancer (19 papers), Cancer-related molecular mechanisms research (17 papers) and MicroRNA in disease regulation (10 papers). Yan Jiao collaborates with scholars based in China, United States and Australia. Yan Jiao's co-authors include Yanqing Li, Yahui Liu, Yue‐Chen Zhao, Tiejun Wang, Ruifeng Zhang, Feng Wang, Zhuo Fu, Baisong Lu, Colin E. Bishop and Sunil George and has published in prestigious journals such as Blood, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Yan Jiao

90 papers receiving 2.1k citations

Hit Papers

<p>The Role of Erastin in Ferroptosis and Its Prosp... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Jiao China 24 1.2k 757 489 221 184 95 2.1k
Zakaria Y. Abd Elmageed United States 31 1.6k 1.3× 824 1.1× 335 0.7× 583 2.6× 324 1.8× 94 2.9k
Horng‐Heng Juang Taiwan 31 1.1k 0.9× 390 0.5× 350 0.7× 420 1.9× 205 1.1× 131 2.3k
Yang‐Sook Chun South Korea 24 1.1k 0.9× 704 0.9× 145 0.3× 204 0.9× 150 0.8× 41 1.9k
Wen Peng China 24 1.5k 1.2× 566 0.7× 262 0.5× 732 3.3× 262 1.4× 60 2.8k
Ku‐Chung Chen Taiwan 34 1.7k 1.4× 979 1.3× 196 0.4× 247 1.1× 286 1.6× 82 2.8k
Nan Wu China 30 1.5k 1.2× 915 1.2× 352 0.7× 265 1.2× 251 1.4× 90 2.6k
Wenyi Qin United States 26 1.4k 1.1× 741 1.0× 169 0.3× 265 1.2× 170 0.9× 88 2.3k
Shan Deng China 26 1.1k 0.9× 514 0.7× 129 0.3× 488 2.2× 241 1.3× 71 2.0k
Inik Chang United States 27 1.9k 1.6× 1.4k 1.9× 231 0.5× 281 1.3× 316 1.7× 48 2.7k
Chuan Liu China 28 1.3k 1.0× 603 0.8× 253 0.5× 436 2.0× 254 1.4× 121 2.3k

Countries citing papers authored by Yan Jiao

Since Specialization
Citations

This map shows the geographic impact of Yan Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Jiao more than expected).

Fields of papers citing papers by Yan Jiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Jiao. The network helps show where Yan Jiao may publish in the future.

Co-authorship network of co-authors of Yan Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Jiao. A scholar is included among the top collaborators of Yan Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Jiao. Yan Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hongyuan, Yan Jiao, Yibing Shi, Qiumei Feng, & Yong‐Guang Gao. (2025). Bipedal DNA walker integrated resonance energy transfer to construct a sensitive electrochemiluminescence biosensor for serotonin detection. Talanta. 293. 128175–128175. 2 indexed citations
2.
Wang, Zhiying, et al.. (2025). Association between estimated glucose disposal rate and gallstone risk in US adults based on NHANES 2017 to 2020. Scientific Reports. 15(1). 26509–26509.
3.
Zhao, Yue‐Chen, Xin Li, Chaoqun Wang, et al.. (2024). Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database. International Journal of Nanomedicine. Volume 19. 11847–11858. 5 indexed citations
4.
Gao, Yong‐Guang, Hongyuan Li, Qiumei Feng, et al.. (2023). A disposable electrochemiluminescence biosensor sensitized with multipedal DNA walker for in situ quenching detection of DNA methylation. Sensors and Actuators B Chemical. 394. 134323–134323. 12 indexed citations
6.
Jiao, Yan, et al.. (2023). Proximity hybridization regulated dual-mode ratiometric biosensor for estriol detection in pregnancy serum. Analytica Chimica Acta. 1278. 341689–341689. 7 indexed citations
7.
Jiao, Yan, et al.. (2022). Immune Infiltration Analysis with the CIBERSORT Method in Lung Cancer. Disease Markers. 2022. 1–7. 22 indexed citations
8.
Ning, Yan, Ling Wang, Yimin Wang, et al.. (2021). Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer. International Journal of Genomics. 2021. 1–13. 4 indexed citations
9.
Jiao, Yan, Dandan Zhao, Xiao Hu, et al.. (2021). MicroRNA-520c-3p suppresses vascular endothelium dysfunction by targeting RELA and regulating the AKT and NF-κB signaling pathways. Journal of Physiology and Biochemistry. 77(1). 47–61. 13 indexed citations
10.
Wu, Zhenhua, Jie Geng, Yunpeng Bai, et al.. (2021). MicroRNA-22 inhibition promotes the development of atherosclerosis via targeting interferon regulator factor 5. Experimental Cell Research. 409(2). 112922–112922. 11 indexed citations
11.
Liu, Zhicheng, et al.. (2020). HN1 as a diagnostic and prognostic biomarker for liver cancer. Bioscience Reports. 40(7). 11 indexed citations
12.
Ji, Xiuru, Yan Jiao, Xiaojuan Zhang, et al.. (2020). MT1-MMP activatable fluorogenic probes with enhanced specificity via high-affinity peptide conjugation for tumor imaging. Biomaterials Science. 8(8). 2308–2317. 8 indexed citations
13.
Ning, Yan, Keren Wang, Ge Gao, et al.. (2020). <p>Wntless (Wls): A Prognostic Index for Progression and Patient Survival of Breast Cancer</p>. OncoTargets and Therapy. Volume 13. 12649–12659. 4 indexed citations
14.
Li, Yanqing, et al.. (2020). <p>Prognostic Significance and Related Mechanisms of Hexokinase 1 in Ovarian Cancer</p>. OncoTargets and Therapy. Volume 13. 11583–11594. 20 indexed citations
15.
Wang, Ruobing, Yan Jiao, Yanqing Li, et al.. (2020). The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer. BioMed Research International. 2020(1). 9519235–9519235. 3 indexed citations
16.
Jiao, Yan, Yanqing Li, Zhuo Fu, et al.. (2019). OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients. Disease Markers. 2019. 1–9. 25 indexed citations
17.
Nie, Yuanyuan, Yan Jiao, Yanqing Li, & Wei Li. (2019). Investigation of the Clinical Significance and Prognostic Value of the lncRNA ACVR2B-As1 in Liver Cancer. BioMed Research International. 2019. 1–13. 17 indexed citations
18.
Zhao, Yue‐Chen, et al.. (2019). Elevated high mobility group A2 expression in liver cancer predicts poor patient survival. Revista Española de Enfermedades Digestivas. 112(1). 27–33. 10 indexed citations
19.
Jiao, Yan, et al.. (2014). Comparison of LAIR-1 genetic pathways in murine vs human internal organs. Gene. 552(1). 140–145. 5 indexed citations
20.
Jiao, Yan, Colin E. Bishop, & Baisong Lu. (2012). Mex3cregulates insulin-like growth factor 1 (IGF1) expression and promotes postnatal growth. Molecular Biology of the Cell. 23(8). 1404–1413. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026